Verition Fund Management LLC
Position in COLL — Collegium Pharmaceutical, Inc
CIK 1454027
GREENWICH, CT
Position in COLL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$350,674
-$917,714 QoQ
Shares Held
10,604
-61.3% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Verition Fund Management LLC holds $14,533,555 across 10 Drug Manufacturers - Specialty & Generic names. COLL ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
211,287 | $5,056,097 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
60,000 | $4,551,000 | |
| 3 | LQDA |
Liquidia Corp
|
60,111 | $2,268,589 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
29,919 | $676,169 | |
| 5 | VTRS |
Viatris Inc
|
39,928 | $539,427 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
13,362 | $402,463 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
18,597 | $364,315 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
This page
|
10,604 | $350,674 |
All Filings in COLL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $350,674 | 10,604 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,268,388 | 27,395 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,274,792 | 43,111 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $441,362 | 14,786 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $419,120 | 14,629 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $542,582 | 14,042 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $334,558 | 10,390 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||